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Background: The enzyme acetyl-CoA carboxylase-alpha (ACC-α) is rate limiting for de novo fatty acid synthesis.
Among the four promoters expressing the bovine gene, promoter IA (PIA) is dominantly active in lipogenic tissues.
This promoter is in principal repressed but activated under favorable nutritional conditions. Previous analyses
already coarsely delineated the repressive elements on the distal promoter but did not resolve the molecular
nature of the repressor. Knowledge about the molecular functioning of this repressor is fundamental to
understanding the nutrition mediated regulation of PIA activity. We analyzed here the molecular mechanism
calibrating PIA activity.
Results: We finely mapped the repressor binding sites in reporter gene assays and demonstrate together with
Electrophoretic Mobility Shift Assays that nuclear factor-Y (NF-Y) and CCAAT/enhancer binding protein-β
(C/EBPβ) each separately repress PIA activity by binding to their cognate low affinity sites, located on distal
elements of the promoter. Simultaneous binding of both factors results in strongest repression. Paradoxically, over
expression of NFY factors, but also - and even more so - of C/EBPβ significantly activated the promoter when
bound to high affinity sites on the proximal promoter. However, co-transfection experiments revealed that NF-Y
may eventually diminish the strong stimulatory effect of C/EBPβ at the proximal PIA in a dose dependent fashion.
We validated by chromatin immunoprecipitation, that NF-Y and C/EBP factors may physically interact.
Conclusion: The proximal promoter segment of PIA appears to be principally in an active state, since even minute
concentrations of both, NF-Y and C/EBPβ factors can saturate the high affinity activator sites. Higher factor
concentrations will saturate the low affinity repressive sites on the distal promoter resulting in reduced and
calibrated promoter activity. Based on measurements of the mRNA concentrations of those factors in different
tissues we propose that the interplay of both factors may set tissue-specific limits for PIA activity.
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Acetyl-CoA carboxylase-alpha (ACC-α) is the rate-
limiting enzyme in de novo synthesis of long-chain fatty
acids [1]. It thus plays an important role in controlling
lipid metabolism [2]. Dysregulation of lipid metabolism
in human and mouse is known to result in metabolic
diseases, such as obesity and diabetes, and may also* Correspondence: Seyfert@fbn-dummerstorf.de
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reproduction in any medium, provided the oraccompany cancer [3,4]. It may also result in severe
metabolic disorders in lactating cows [5]. Hence, an
improved understanding of the regulation of ACC-α ac-
tivity might help developing new strategies to avoid
health problems associated with perturbed fat metabol-
ism in keeping of dairy cattle.
Multiple promoters express the mammalian ACC-α
encoding-gene. Their activities are differentially influ-
enced by diets and hormones (e.g. insulin and glucagon)
[1,6]. The bovine gene was previously known to be
expressed by three promoters [7-9]. Among them, the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was supposed to be nutritionally regulated. However, we
recently identified an additional fourth promoter located
~41 kbp more upstream, similar as previously reported
from sheep [10]. We validated in separate experiments
that this promoter is also active in cattle, mainly in the
brain (EMBL Acc No FN185962, FN185963). To avoid
confusion regarding the designation of the various pro-
moters, we adopt here the recently proposed nomencla-
ture of ACC-α promoters (Additional file 1: Figure S1)
[6]. Thus, we now name, for cattle the most 5´-located
promoter as PI and designate the nutritionally regulated
promoter as PIA (previously known as “PI” [7]). We
keep the previous designations for the constitutive pro-
moter PII [8] and the mammary gland expressed and
lactationally activated PIII [9].
PIA (Additional file 1: Figure S1), but not the other
promoters, is known as the dominant ACC-α promoter
of lipogenic tissues, such as liver, adipose tissues and
mammary gland in ruminant and rodent species [11-13].
Activity of this promoter is controlled by insulin through
an element binding the upstream stimulatory factors
(USF1 or USF2) [14]. Glucose regulates PIA via a carbo-
hydrate response element (ChoRE) located on the prox-
imal promoter [15].
Promoter PIA is basically repressed [7,16,17]. Coarse
mapping of structural elements necessary for repression
of PIA in cattle had revealed that the repressor consists
of potentially three distinct elements which are sepa-
rated by more than 1000 bp [7]. The molecular nature
of the repressor and the repressive mechanism control-
ling PIA activity remained unknown, so far. Cooper-
ation of at least two of these structural elements was
shown to be necessary in order to exert repression [7].
PIA from rat is also repressed by a distal element [16].
Over- expression of C/EBPα or− β factors may over-
come repression of the rat PIA by binding to the prox-
imal promoter and stimulate its activity in reporter
gene assays [16,17].
C/EBP factors are ubiquitously expressed and are
known to play an essential role in controlling the expres-
sion of genes with relevance for energy metabolism
[18,19]. The C/EBP factor family includes six structurally
related members (α, β, δ, E, γ, ζ). Their specific N-
termini encompass not only activation domains but also
repression domains. The conserved C-termini constitute
a DNA binding domain while an internal leucine zipper
domain is necessary for factor dimerization [20]. These
factors have a quite complex repertoire of mechanisms
to eventually regulate expression of their target genes,
involving factor dimerization, either as homo- or hetero-
mer. Differential phosphorylation and synthesis of differ-
ent isoforms were also shown to regulate activity of
those factors [20,21].C/EBPα is known to interact with NF-Y factors
[22,23]. The ubiquitously expressed NF-Y factor family
consists of three subunits, NF-YA, -B and -C. Subunits -
B and -C are constitutively expressed, while the expres-
sion of NF-YA is regulated [24,25]. NF-YB and -C have
to form a dimer before NF-YA can bind to the complex.
Only that trimer of NF-Y factors can bind to a CCAAT-
box on the DNA. Mutation of three amino acids in the
binding domain of the NF-YA subunit abrogates DNA-
binding of the entire NF-Y complex [26]. NF-Y may act
as a bifunctional regulator by either repressing or acti-
vating transcription during different physiological condi-
tions [27].
It was found in rat and goat that the presence of this
distal repressor reduces the insulin mediated stimulation
of PIA activity [14,15]. Hence, quite obviously does the
activity of the repressor influence and eventually bias the
analysis of the nutritionally and hormone mediated fine
tuning of PIA activity. Therefore, we set out to
characterize the molecular nature of that general repres-
sor of PIA in cattle. We first finely mapped the cis-
relevant repressive elements and determined in mutation
analyses and EMSA assays that NF-Y and C/EBP factors
act as repressors. Surprisingly, we found that these fac-
tors both are also crucial enhancers of PIA activity, if
they are bound to the proximal promoter. We provide
evidence that interaction in trans allows the distally
bound repressors to inhibit the stimulatory effect of the
proximally bound partner factors. Measurements of the
endogenous mRNA levels suggest that the proportion of
these factors may set coarse tissue-specific limits for the
overall PIA promoter activity.
Results
PIA is the nutritionally regulated promoter
We validated first that indeed the activity of PIA is
nutritionally controlled, using the nutritionally
modulated expression of the ACC-α in liver as
paradigm. To this end we selected four first lactat-
ing cows and took biopsies from their livers. Subse-
quently the cows were starved for 43 h, and the
livers were biopsied again. Sampling was repeated
subsequent to refeeding the animals for 29 h again.
Starvation decreased the total ACC-α mRNA con-
tent down to ~32% of that found in the livers of
the well fed animals (Figure 1). This decrease was
caused primarily by a cessation of PIA activity, as
indicated by a >94% reduction of PIA derived tran-
scripts. The transcripts derived from the house
keeping promoter (PII), on the other hand, only
decreased by ~19%. The data show that the level of
PIA derived transcripts in the liver reflects the
metabolic state of the animal, better than the con-
































Figure 1 Effect of starvation and refeeding on the relative
abundance of ACC-α mRNA molecules derived from PIA, PII,
and from all promoters (total) in the liver. The relative
concentration of mRNA molecules derived from PIA, PII and all
ACC-α encoding messages were measured from liver biopsies.
These were taken from normally fed animals (Fed), probed again
after starvation (43 h, Starved) and after subsequently refeeding
them for 29 h (Refed). Values were normalized relative to the
mean concentrations as measured from the well fed animals, set
as 100 %. Shown are the mean values (±S.E.M., n = 4). Statistical
significance of differences was calculated against respective Fed
samples (* P< 0.05; ** P< 0.01).
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amount of ACC-α transcripts. Strong nutrition-
dependent regulation of PIA activity in the liver
was also recorded in a different experiment, in
which a group of six cows was kept on a minimal
energy, straw based diet for 60 h [28]. This diet
supplied only 16 % of the energy contained in the
normal diet having been fed to the control group.
The concentration of PIA derived ACC-α tran-
scripts was proportionally reduced, down to 19 %
(Table 1).Table 1 Relative mRNA levels of ACC-α PIA, NF-YA and C/EBP
Copies Liver
Diet Straw Normal
ACC-α PIA x 104 0.10 ± 0.01 a 0.52 ± 0.22 b
NF-YA x 103 8.94 ± 1.05 7.64 ± 0.71
C/EBPβ x 106 4.37 ± 0.25 3.71 ± 0.80
NFYA:C/EBPβ x 10-3 2.06 ± 0.24 2.44 ± 0.64
NEL MJ 18.0 ± 1.1 110.2 ± 11.2
Fat g/kg DM nd nd
Carbohydrate g/kg DM nd nd
n 6 6 8
Mean values (±S.E.M.). Different superscripts (“a” and “b”) indicate statistically differ
Lactation; nd, not determined; n, number of animal.Distal NF-Y and C/EBP binding sites are involved in PIA
repression
We finely mapped with serial deletions of promoter seg-
ments the structural elements contributing to PIA re-
pression in murine mammary epithelial model cells
(MEC) HC-11. MEC cells are a relevant model for fatty
acid synthesis, since they synthesize in vivo abundant
amounts of milk fat [29] and the previous functional
characterization of PIA had in part been conducted
using these cells [7]. We found that two elements (A
and C) from among three potentially relevant elements
must be present to repress the PIA activity (Figure 2A
and Additional file 1: Figure S2A). Deletion of either
element increased the promoter activity> 3-fold. Stron-
gest promoter activation was achieved, if both repressive
sites were deleted. We cloned to this end a short seg-
ment comprising only 127 bp of the proximal PIA pro-
moter (Driver, Figure 2A and Additional file 1: Figure
S2A). This element very actively expresses the reporter
gene, resulting in approximately 10-fold of the reporter
activity measured from the promoter-less pGL3b (Fig-
ure 3B), confirming previous observations [7]. The ex-
tent of enhanced activity of this short minimal promoter
indicates an additive effect of both repressive sites.
More detailed deletion analyses revealed that the 5´-
located half of element A is the key component of the
repressive element (Figure 2A and Additional file 1: Fig-
ure S2B). Abolishing the NF-Y factor binding site in this
element via point mutation increased promoter activity
~3-fold, indicating some relieveof repression (Figure 2B,
clone Am). EMSA assays demonstrated that NF-Y fac-
tors can indeed bind to a probe harboring the 5´-half of
element A (Figure 2C, lane4). We used for these assays
nuclear extracts from murine HC-11 cells, from primary
bovine MEC cells (pbMEC) or from the lactating udder
of a cow (bMG). The specific complex (NF-Y) could be
inhibited by the addition of a 100-fold molar excess of a
competitor, harboring a NF-Y consensus motif (Fig-
ure 2C, lane3) embedded into otherwise completely PIA-β in various tissues under different nutritional conditions
Adipose Mammary gland
Fat Starch Starch Fat
6.81 ± 2.24 8.49 ± 4.86 19.79 ± 4.79 42.85 ± 12.98
10.41 ± 0.97 18.57 ± 7.61 8.38 ± 1.48 7.56 ± 1.06
2.45 ± 0.35 3.08 ± 1.10 0.62 ± 0.09a 0.36 ± 0.06 b
4.69 ± 0.71 6.45 ± 0.90 14.07 ± 1.87a 25.89 ± 5.08 b
nd nd nd nd
51 28 28 51
31 100 100 31
8 8 8 8
ent values (P< 0.05) within the respective tissue. NEL, Net Energy content for
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Figure 2 NF-Y and C/EBP binding sites in element A and C respectively in the distal region are involved in PIA repression. (A) Genomic
organization of PIA. The distal region includes three putative repressive elements, as revealed by coarse mapping analyses involving StuI and NdeI
deletions, respectively (filled boxes, element A, B, C). Element A harbors a NF-Y attachment site (filled circle), and element C contains a C/EBP
binding site (filled square). The core binding sequences of those factors and mutational derivatives are shown. The proximal driving region
features a NF-Y site (open circle) and a C/EBP binding site (open square). ‘+1’ represents the tsp. (B) Abrogation of NF-Y binding and C/EBP
binding in the distal PIA relieves repression in reporter gene assay. Shown are mean values (+ S.E.M.) of at least three independent experiments,
each assayed in triplicate. Significance of difference relative to construct −1045 (WT) is indicated (** P< 0.01). (C) EMSA analysis of transcription
factors binding to element A. The labeled probe A_WT (Additional file 1: Table S4) is bound by NF-Y factors from nuclear extracts of HC-11,
pbMEC and bMG (“S”) and is supershifted (SS) by the addition of antibodies against NF-YA (αA). Lanes: FP, free probe; C and Y, competition with
100-fold molar excess of the unlabeled A_WT probe and a probe harboring an NF-Y consensus site respectively (Additional file 1: Table S4).
(D) EMSA validation that C/EBP factors bind to element C. Nuclear extracts from HC-11 cells were incubated with the radioactively labeled probe
C_WT (Additional file 1: Table S4). Lane: C, competition with 100-fold molar excess of unlabeled C_WT; S, shift; αB, supershift (“SS”) with anti-C/EBP
antibodies; Cm2, competition with 100-fold molar excess of the unlabeled probe mutated as shown in Figure 2A.
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http://www.biomedcentral.com/1471-2199/13/21unrelated DNA sequence. A rabbit antibody specific for
NF-YA supershifted the protein-DNA complex (Figure 2C,
lane7, 9). The NF-Y specificity of this supershift is clearly
demonstrated, since an antibody directed against C/EBP
did not supershift this band (Additional file 1: Figure S2C,
lane4). Introducing a mutation (“Am”) into the unlabeled
“cold” competitor in EMSA assays abolished competitionS
SS
FP   C   Y    S   A FP  C 
NF-Y
Lane 1    2     3    4     5              6    7  
NF-Y

















Figure 3 (See legend on next page.)(Additional file 1: Figure S2C, lane9). The data together
suggest that NF-Y factors binding to this site constitute
the active component of the 5´-half of the PIA repressor.
We characterized the repressive principle in element C
using a similar strategy. Deletion analyses in reporter
gene experiments indicated a putative C/EBP binding site
as a candidate sequence motif (Figure 2A, B and  m1  S  B S    B S    B





















(See figure on previous page.)
Figure 3 Binding of NF-Y and C/EBP factors to the proximal PIA drives activity. (A) Map and sequences of the NF-Y and C/EBP binding sites
on the proximal PIA. Core motifs (underlined) of the respective binding sequences and mutations are shown, as they have been included in
EMSA and reporter gene analyses. The tsp in the C/EBP motif (“A” nucleotide, bold, italicized) is indicated. (B) Mutation of the binding sites of
NF-Y (Ym) as well as of C/EBP (m1, m2) significantly reduce the reporter genes activity (open columns). Joint co-transfection of expression
constructs for all three NF-Y factors (NF-YA -B, -C) significantly increase activity of WT-promoter, but not of the construct Ym. Mean values (+ S.E.
M.) from one out of three experiments (Ym) or six independent experiments (C/EBP mutation), always assayed in triplicate and normalized
against the WT construct. (C) EMSA analyses of the proximal NF-Y and C/EBP binding sites. Left: Nuclear extracts from HEK293 cells over-
expressing jointly the factors NF-YA, -B, -C were incubated with the probe harboring the proximal NF-Y binding site (pNF_WT, Additional file 1:
Table S4). The shifted band (S) was supershifted (SS) by anti-NF-YA antibodies (αA). Right: The labeled probe was the proximal C/EBP site
(pCE_WT, Additional file 1: Table S4). Multiple specific shift bands (S) appeared with nuclear extracts from HC-11 cells, pbMEC, or bMG. Anti-C/EBP
antibodies (αB) caused supershifts (SS). Lane designations are similar to Figure 2C and D; m1, competition with 100-fold molar excess of
unlabeled probe, mutated as shown in Figure 3A. “ns” represents a non-specific band.
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as a probe in EMSA analyses showed that mutation
of the C/EBP binding site abolished factor binding
(Figure 2D, lane2, Cm2) and an antibody against C/EBPβ
supershifted this band (Figure 2D, lane4). Mutation of
the C/EBP-core recognition motif relieved repression to
the same extent as deleting that element (compare Fig-
ure 2B, clone Cm1 vs Additional file 1: Figure S2A, clone
ΔStu). Hence, the relevant DNA-sequence element
within the repressive element C is a C/EBP binding site.
Our data together show that the structure of the bovine
PIA repressor consists of a distal NF-Y binding site and a
more proximally residing C/EBP binding site (Figure 2A).
These sites cooperate functionally to exert full repression.
C/EBP and NF-Y factors activate PIA by binding to
proximal promoter segments
Unexpectedly, cloning and co-transfecting together
expression constructs for all three different NF-Y
factors (A, B, C) consistently increased the activity
of our long PIA reporter construct. Moreover, we
previously reported that cotransfecting expression
constructs for any of the C/EBP-factors -α, -β, -δ, -
E increased significantly the activity of this pro-
moter. C/EBPβ had the strongest activation poten-
tial [11]. Sequence analysis of the PIA DNA
sequence revealed putative binding sites for both
factors, indeed, located on the proximal promoter
(Figure 3A). These are located on our minimal-
127 bp promoter construct. When expression con-
structs for all three NF-Y subunits (A, B, C) were
jointly co-transfected together with the reporter
gene, they increased the reporter activity by 60–
100% (Figure 3B). Abrogation of the NF-Y binding
site via point mutation reduced the promoter activ-
ity by ~60% (Figure 3B, clone Ym). In support, co-
transfected NF-Y expression constructs did not en-
hance the activity of the reporter harboring the
mutated NF-Y binding site (Figure 3B, clone Ym,
black column). EMSA analysis confirmed that over-
expressed NF-Y-factors indeed may bind to thiselement (Figure 3C, lane4). The unlabeled probe
bearing a NF-Y consensus binding site (Y) com-
peted away the shift band (Figure 3C, lane3), and
anti-NF-YA antibodies (αA) supershifted this band
(Figure 3C, lane5).
EMSA assays demonstrated that nuclear extracts from
HC-11 clearly shifted a radioactively labeled probe bear-
ing the proximal C/EBP motif (Figure 3C, lane9) which
could also be supershifted by antibodies specific for C/
EBPβ (Figure 3C, lane10, 12, 14). Similarly, nuclear
extracts derived either from pbMEC or bMG also
formed several complexes with that probe, some of
which could be supershifted by those antibodies. Abro-
gating this site via point mutation reduced the promoter
activity down to ~30% of the WT activity (Figure 3B,
clones m1 and m2). Considering that this C/EBP binding
site comprises the most 3´-located transcriptional start
point (tsp) of PIA [7], we inserted two different muta-
tions into this sequence element, one eliminating the
“A” nucleotide forming the WT tsp while the other
maintained the tsp (Figure 3B; clones m1 and m2, re-
spectively). Both mutations resulted in a comparable and
diminished activity of the reporter. The data together
show that C/EBP as well as NF-Y factors activate the
proximal PIA promoter.
The distal sites bind the respective factors with much
lower affinities than the proximal sites
The data presented the paradox that NF-Y as well
as C/EBP-factors may either function as repressor
or as driver of PIA activity, depending on binding
to either the distal or the proximal sites on the
promoter. We realized, however, in the course of
the EMSA analyses that the binding affinities of the
distal and the proximal sites were different. To
quantitatively evaluate the differential binding affin-
ities of the distal and proximal DNA-sequence
motifs for both, NF-Y and C/EBPβ, we labeled as
probes double stranded oligonucleotides harboring
the core consensus motifs for either factor and em-
bedded these into DNA-sequences which were
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(NF-Y consensus, C/EBP consensus oligonucleotides,
Additional file 1: Table S4). However, we choose as
unlabeled competitors double stranded oligonucleo-
tides with sequences representing either the distal
or the proximal binding sites for the respective fac-
tors (for NF-Y: oligonucleotides A_WT, and
pNF_WT; for C/EBP: oligonucleotides C_WT,
pNF_WT, respectively; Additional file 1: Table S4).
We used nuclear extracts for the assays prepared
from cells overexpressing either all three NF-Y fac-
tors, or the factor C/EBPβ. Regarding the proximal
NF-Y binding site (Figure 4A), we found that a 25-
fold molar excess of the competitor would reduce
the amount of the shifted probe down to 20%1     2    3    4    5     6     7    8    9   10  11   12   13 



























































Figure 4 Comparison of the binding affinities of the distal and proxim
activity. (A) Affinity comparison of the proximal and distal NF-Y binding si
over-expressing the three bovine NF-Y factors (A, B, C). Sequences of the la
distal NF-Y (A_WT) and proximal NF-Y sites (pNF_WT) are shown in Additio
C, competition with 100-fold molar excess of unlabeled probe (self); S, shift
to the reactions, as resolved in lanes 4–8 or lanes 9–13 were 10, 25, 50, 100
EBP binding sites. These samples were run out on the same gel. Nuclear ex
binding domain of the bovine C/EBPβ factor. Sequences of the labeled C/E
EBP distal (C_WT) and C/EBP proximal (pCE_WT) are shown in Additional fi
EBPβ factors on the proximal PIA activity. The proximal PIA reporter constru
cloning vector (EV) or with constructs expressing C/EBPβ or NF-Y subunits,
(±S.E.M.) are representative for two experiments, each assayed in triplicate.
control having been cotransfected only with empty vector (grey column), *
HEK293 cells were co-transfected with the −127 PIA reporter gene and exp
YAm29, -YB, -YC. Nuclei were used for ChIP assays using antibodies against
four qPCR assays of the amount of recovered PIA promoter molecules (**P
modulates PIA activity. NF-Y and C/EBP factors (black) having bound to the
contact the respective other factor (open) having bound to the proximal d
to scale. “+1” represents the tsp.(Figure 4A, lane 5 and Additional file 1: Figure S3).
In stark contrast, it required as much as a 200-fold
molar excess of the distal attachment site to obtain
the same degree of competition for the probe (Fig-
ure 4A, lane 13 and Additional file 1: Figure S3).
An even larger difference in competition efficiency
was observed for the C/EBP attachment sites (Fig-
ure 4B). As little as a 10-fold molar excess of the
proximal site competitor reduced the shifted
amount down to less than 20% (Figure 4B, lane 4
and Additional file 1: Figure S3). However, even a
200-fold molar excess of the distal site would still
leave behind ~40% of the radioactive probe in the
shifted band (Figure 4B, lane 13 and Additional file
1: Figure S3). These data demonstrate that theFP  C    S
proximal distal





















al NF-Y and C/EBP sites and influence of these factors on the PIA
tes of PIA. Nuclear extracts were prepared from HEK293 cells jointly
beled NF-Y consensus probe and of the unlabeled competitor of the
nal file 1: Table S4 cf (Figures 2A and Figure 3A). Lane: FP, free probe;
. The fold molar excess of the respective unlabeled competitors added
, 200-fold of the labeled probe. (B) Same as A, but evaluating the C/
tracts were prepared from HC-11 cells over-expressing the DNA
BP consensus probe, the unlabeled oligonucleotide competitors of C/
le 1: Table S4 cf (Figure 2A and Figure 3A). (C) Effects of NF-Y and C/
ct −127 was transfected into HC-11 cells, together with the empty
as indicated. The functional NF-Y trimer can quench this effect. Results
Statistical significance of the differences was calculated relative to the
*P <0.01. (D) NF-Y factors interact with C/EBPβ having bound to PIA.
ression constructs for the factors C/EBPβ (tagged with a flag), NF-
C/EBPβ or NF-YA or control IgG. Data are mean values (±S.E.M.) of
<0.01, as compared to control IgG). (E) A master control unit
distal repressive factor binding sites may be looped back to physically
river region. This interaction lowers PIA activity. The map is not drawn
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finities for the respective factors than thoseproximal
sites.
NF-Y quenches the stimulating effect of C/EBPβ
We analyzed how NF-Y and C/EBPβ together might
repress PIA. Therefore, we co-transfected both factors
either alone or jointly together and recorded the effect
on the activity of the short PIA promoter segment.
Both factors could separately activate the PIA reporter
gene activity (Figure 4C and Additional file 1: Figure
S4B). Co-transfection of expression constructs for all
three NF-Y factors abolished the stimulatory effect of
C/EBPβ (Figure 4C, Additional file 1: Figure S4A and
Additional file 1: Figure S4B). Quenching of the C/
EBPβ associated transactivation potential is dosage-
dependent, since increasing amounts of transfected
DNA caused stronger quenching of the stimulatory
capacity of C/EBPβ (Additional file 1: Figure S4A).
Quenching required that all three NF-Y subunits (A, B,
C) were jointly expressed (Additional file 1: Figure
S4B). We also found that NF-Y must not necessarily
bind to the DNA to reduce the transactivating poten-
tial of C/EBPβ. This was shown by replacing three
amino acids in the factor NF-YA. This replacement is
known to abolish DNA binding of the NF-Y complex
[26]. We found that inclusion of this mutated NF-
YAm29 subunit was as efficiently quenching the C/
EBPβ mediated PIA stimulation as the wild type NF-
YA subunit (Additional file 1: Figure S4B).
The observation that the NF-Y factors might exert in
trans their blocking effect on the C/EBPβ mediated acti-
vation of PIA was experimentally augmented. We
expressed together in HEK293 cells the factors NF-
YAm29, NF-YB, NF-YC and C/EBPβ and cotransfected
the short PIA reporter gene. We analyzed from the same
cells in ChIP assays if NF-Y factors may physically inter-
act with C/EBPβ having bound to PIA. To this end, we
measured in qPCR the amount of promoter molecules
recovered by antibodies directed against C/EBPβ and
NF-YA. We choose PCR amplification primers spanning
the C/EBP site, but not the NF-Y binding site. We found
that the antibodies against both factors retrieve approxi-
mately similar amounts of PIA (Figure 4D). These data
show that NF-Y factors can indeed bind in trans to the
C/EBP factor.
Different tissue-specific levels of both, PIA activity and C/
EBPβ mRNA concentrations
We examined if our in vitro derived data concerning
mechanism regulating PIA activity are of physiological
relevance in vivo. We exploited for this purpose tissue
samples derived from two different stacks of animals.
Livers were taken from those 12 lactating cows havingbeen fed normal and energy reduced straw diets, having
above already been referred to. In addition, adipose and
mammary gland tissues were collected from 16 mid lac-
tating cows having been fed 30 days before slaughter ei-
ther a norm diet or a fat enriched diet. Experimental
conditions for those two groups of animals have exten-
sively been described [28,30].
We compared the PIA activity in different tissues
to the mRNA abundance of both families of tran-
scription factors. The concentration of PIA derived
transcripts differed >100-fold between liver and lac-
tating mammary gland, while intermediate concen-
trations were found in adipose tissue (Table 1).
This indicates substantial tissue-specific differences
in PIA activity. The concentration of NF-YA-
encoding mRNA molecules was fairly constant.
However, the concentrations of C/EBPβ varied be-
tween the tissues. Analysis of a potential inter-
dependence between the mRNA concentrations of
those factors revealed a strikingly clear correlation
ofPIA derived transcripts with the ratio between
the tissue-specific mean values of NF-YA mRNA
copies over those of C/EBPβ (Additional file 1: Fig-
ure S5). The correlation between these parameters
is statistically high and significant (full symbols; r,
0.997; p< 0.001). Moreover, including the mean
values derived from the different nutritional sub-
groups (Table 1) into this correlation analysis
reveals that the nutrition-dependent different mean
values also fit very well to this correlation (open
symbols, Additional file 1: Figure S5). However, due
to the eventually large individual variation, not all
differences between the subgroup means of a given
tissue are statistically significant cf (Table 1). No
significant degree of correlation was found if all the
individual data were considered, due to the high
degree of individual variation. We found the highest
degree of individual variability for the levels of PIA
derived transcripts (CV, 116), while the same par-
ameter was much lower for the mRNA concentra-
tions of those transcription factors (52% and 5%,
for C/EBPβ and NF-YA respectively).
The mRNA concentrations of both factors are very
different in the respective model cells. We found in
those pbMEC cultures from cows ~40fold higher con-
centrations of the NF-YA (3.1 +0.2 x 105, n = 3) and only
~1% of the C/EBPβ mRNA concentration (5.4 + 0.32 x
103, n = 3) than found in vivo in udder tissue. This very
low endogenous concentration of the C/EBPβ mRNA in
the pbMEC model cells may relate to the observation
that overexpression of the C/EBPβ mRNA encoding vec-
tor in these cells significantly increased the activity of
the long PIA-reporter construct. This would not be pre-
dicted by the above model. The C/EBPβ mRNA
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ously reported from us for the murine HC-11 MEC
model cell [11]. Neither of these model cells endogen-
ously expresses PIA.
Discussion
We initiated this study in order to characterize the mo-
lecular principle repressing the general activity of PIA of
the ACC-α-encoding gene in cattle. To ensure the
physiological relevance of our analysis, we first validated
for the cow that PIA, indeed is the nutritionally regu-
lated promoter. This was previously only assumed to be
the case [7] by analogy with the situation found in other
animals including rat [31,32]. We also excluded that a
more upstream located ACC-α promoter “PI” (EMBL
Acc No FN185962) would override those transcriptional
controls of PIA. We found this promoter to be promin-
ently expressed in the brain (Shi, unpublished), just as
that from sheep [10]. Significantly, transcripts derived
from PI do not contain exon1A derived sequences, as
revealed by 5´-RACE experiments (EMBL acc No
FN185963). Thus, transcripts containing exon1A truly
stem from PIA and thus are diagnostic for the activity of
PIA.
NF-Y and C/EBP factors may either repress or activate PIA
activity, depending on the binding site in the promoter.
Our mapping and mutation data indicate that struc-
turally the bipartite PIA repressor is composed of
attachment sites for CCAAT-box binding transcrip-
tion factors of the NF-Y and of the C/EBP families,
binding to the distal promoter. Their repressive
strength is additive, at least. However, we also
observed that attachment sites for both transcrip-
tion factors on the proximal promoter function as
activators for PIA activity. Hence, the binding pos-
ition rather than the nature of the CCAAT-box
binding factor itself determines its function as ei-
ther to repress or to activate PIA activity.
The bipartite structure of the PIA repressor in cat-
tle is similar to that of the rat PIA promoter [17].
The 5´-part of the rat PIA repressor is formed by a
microsatellite, a CA28 repeat. It is not known which
factor might bind there. The distal element of the bo-
vine PIA repressor resides in an Art2 retroposon
element [7]. We now found that NF-Y factors may
bind there to repress PIA activity. The 3´-part of the
repressor was found in rat [16,17] as well as in cattle
(this study) to depend on a C/EBP factor binding site.
Hence, the structurally divergent, yet physiologically
equivalent PIA promoters of rat and cow feature a
similar bipartite structure of that repressor. However,
the structures of the 5´-segment of that repressor are
completely unrelated between cattle and rat.NF-Y is known to regulate the transcription of many
genes by interacting with the CCAATbox sequence
motif, either enhancing [22,33,34] or dampening expres-
sion [27,35]. Dual NFY binding sites of high and low
binding affinities have been reported to reside in the
promoter of the human von Willebrand factor (VWF)
gene [36]. The low affinity site, located in exon1, was
found to repress VWF promoter activity, while the high
affinity site functions as an activator, quite similar to our
findings in the cattle PIA promoter. Interestingly, the
high affinity activator binding site of the human VWF
gene spans the positions from −30 to +1, very compar-
able as found in the bovine PIA. The repressive function
of NF-Y involves interaction with histone deacetylase
(HDAC). NF-Y recruits HDACs to the VWF promoter
thus inhibiting the promoter activity in non-endothelial
cells. This repression depends on NFY-binding to that
downstream repressive site [37].
Likewise, we found that two C/EBP binding sites
are crucially involved in regulating the PIA pro-
moter activity. The proximal binding site contri-
butes to basal promoter activity. Stimulation of
gene expression through C/EBP factors has often
been found [38-40]. It has also been observed, that
C/EBP factors may repress transcription [15,41],
eventually through repressive family members, such
as C/EBPγ and -ζ, or repressive isoforms [19] or
through the interaction with HDAC in various
physiology conditions [42]. Hence, also the C/EBP
family of transcription factors is known to either
positively or negatively regulate gene expression.
Our data show that two criteria determine whether
these factors activate or repress PIA promoter activity:
First, their binding to either the distal repressor or prox-
imal driver region matters but also, second their even-
tual interaction.
NF-Y represses the activating capability of C/EBPβ via
protein-protein interaction
We observe, as a novel mechanism that the functional
NF-Y factor complex reduces the strong enhancing ef-
fect of C/EBPβ by protein-protein interaction. The re-
pressive effect of NF-Y on the C/EBPβ mediated
activation may be unique to PIA of the ACC-α in cattle.
In contrast to our observation, it was found in mouse
that the interaction between NF-Y with C/EBPα
strongly enhances the stimulatory effect on the amelo-
genin gene promoter activity. ChIP experiments indi-
cated in this example that NF-Y interacts in trans with
C/EBPα [23]. C/EBPδ could eventually substitute for the
role of the C/EBPα factor [43]. Similarly, expression of
the human microsomal-epoxide-hydrolase gene (EPHX)
is stimulated through interaction of promoter bound
NF-Y factors with C/EBPα. This interaction must be
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directly the factor C/EBPα [44].
We also found that protein-protein interaction med-
iates the repressive function of NF-Y factors on the
stimulating effect of C/EBPβ, based on two lines of evi-
dence. Reporter gene assays involving the mutated
DNA-binding incompetent factor NF-YAm29 and ChIP
data congruently support the conclusion that the repres-
sive effect of NF-Y on C/EBPβ mediated enhancement
of PIA activity is mediated in trans.
Our data may therefore be summarized in a model of
a master control unit regulating PIA activity (Figure 4E).
Small amounts of NF-Y and C/EBPβ factors are suffi-
cient to saturate the proximal binding sites and to acti-
vate the promoter. Hence, their high binding affinity for
those factors ensures that PIA in principal could actively
transcribe the gene, almost in any tissue given that both
transcription factors are ubiquitously present. Indeed, a
pivotal role of C/EBPβ in lipid synthesis has recently
been proven by showing that functional disruption of
the C/EBPβ-encoding gene results in impaired fat accu-
mulation in adipose tissue [41].
However, recruitment of a transcription factor to a
high affinity site cannot reflect different factor concen-
trations, since high affinity sites respond similarly to a
switch (e.g. either “on” or “off”) rather than like an ad-
justable lever. To nevertheless achieve regulation, PIA
activity is thus dampened by the factors binding to
those distal, low affinity sites. Much higher factor con-
centrations are necessary to saturate them. Hence, the
probability that they are occupied can reflect different
factor concentrations. The very large difference
observed between the binding affinities of the proximal
vs distal C/EBP binding sites suggests that these might
be of pivotal significance in this regard. Once those dis-
tal, repressive sites are occupied, they might physically
be brought into contact with the reciprocal factor resid-
ing on the proximal promoter to repress via protein-
protein interaction the activation potential. This would
structurally require that the promoter elements separat-
ing the different components of the master control unit
are looped out.
C/EBPβ may be the prominent factor to constrain the
tissue-specific PIA activity
PIA activity, as assessed on the basis of PIA
derived transcripts differs significantly between tis-
sues, similar as it is found for the balance between
the concentrations of NF-YA and C/EBPβ-encoding
mRNA molecules. The latter ratio is mainly influ-
enced by large tissue-specific differences of the C/
EBPβ mRNA concentration. Assuming that the
mRNA concentrations reflect the factor concentra-
tions we then observe, in keeping with our modelthe highest PIA activity in the lactating mammary
glands, where also the C/EBPβ mRNA concentra-
tions (e.g. factor concentrations) are least (Table 1).
Moreover, the diet dependent changes of PIA activ-
ity in this gland are inversely correlated with the
C/EBPβ mRNA concentrations. The average PIA ac-
tivity is highest in the mammary gland of cows
having been fed with a fat-enriched diet and con-
comitantly we found that the C/EBPβ mRNAcon-
centrations are least under these conditions. C/
EBPβ is also found to be regulated in the mam-
mary gland of the mouse by the fat content of the
diet [29], as well as with different stages of lacta-
tion [45].
Taken together our data suggest that tissue-specific
alterations in the proportion of NF-Y and C/EBPβ adjust
very different set points for the gross PIA activity around
which other factors may finely tune the individual PIA
activity according to the acute actual needs.
Model cells do not properly reflect the situation in the
tissues
It would have been desirable to validate this model
through manipulation of the ratio of NF-Y / C/EBPβ fac-
tors. However, the initial mRNA concentrations for both
factors are so vastly different in the pbMEC cells com-
pared to the situation found in the udder tissue that a
direct comparison is not really meaningful. Indeed, it is
long known that these pbMEC express neither genes for
milk protein- nor milk fat-synthesis [46]. They also do
not express the endogenous ACC-α PIA (own measure-
ments, data not shown). Moreover, we previously
attempted to establish primary cultures of liver cells
from cattle as relevant cell model for the analysis of PIA
regulation. We found that within 1 h after extirpation
the cells would only feature 10% of the original PIA
mRNA concentration and another 2.5 h later this con-
centration was barely measurable, down to ~3% of the
original mRNA concentration.
Hence, these cell models do not maintain and reflect
the developmentally finely tuned situation found in vivo
in the specific tissue within the organ.
Conclusions
The proximal promoter segment of PIA appears to be
principally in an active state, since even minute concen-
trations of both, NF-Y and C/EBPβ factors can saturate
the high affinity activator sites. Higher factor concentra-
tions will saturate the low affinity repressive sites on the
distal promoter resulting in reduced and calibrated pro-
moter activity. Based on measurements of the mRNA
concentrations of those factors in different tissues we
propose that the interplay of both factors may set tissue-
specific limits for PIA activity.
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Animals
All animal experiments were performed according to
protocols approved by the relevant authorities (Lande-
samt für Landwirtschaft, Lebensmittelsicherheit und
Fischerei, Mecklenburg-Vorpommern).
Reporter gene constructs
All oligonucleotides used throughout the study are
listed in Additional file 1: Table S1. Establishment of
the constructs in pGL3basic (Promega) is described
in Additional file 2: Supplementary materials and
methods.
Fusion PCR
Fusion PCR was performed as described [47]. All pri-
mers are listed in Additional file 1: Table S2, and a
detailed protocol is given in Additional file 2: Supple-
mentary method.
Cell culture, transient transfection and luciferase assays
Cells from the established murine mammary epithelial
cell line (HC-11), primary bovine Mammary Epithelial
Cells (pbMEC) and human Embryonic Kidney Cells
(HEK293) were cultured as previously described [7,48].
Transient transfection and luciferase assays were done
essentially as described [7]. Co-transfection of the vector
phRL-TK renilla (Promega) allowed to eventually nor-
malizing for slightly varying transfection efficiencies.
The normalized data were expressed as multiples of the
activity of the promoterless pGL3basic clone, the hosting
vector for the different promoter fragments.
Quantitative real-time PCR
The abundances of ACC-α transcripts derived from PIA,
PII, or from all promoters (total), and those encoding NF-
YA and C/EBPβ were measured by quantitative Real-time
PCR (RT-qPCR) assays as described [7,8]. Sampling of the
biopsies from liver, mammary gland and fat was already
described [28]. Tissues were snap-frozen in liquid nitrogen
immediately after collection. One hundred milligram of
ground tissue in 1 ml of TRIzol reagent (Invitrogen) was
homogenized with Ultra-Turrax T25 for 10 s. After
addition of 0.2 ml of chloroform and centrifugation at
12,000 g for 15 min at 4°C, aqueous phase was transferred
for total RNA precipitation by adding 1 volume of isopro-
panol. The RNA pellet was washed with 1 ml of 70% etha-
nol and air-dried. RNA was dissolved in DEPC-treated
water and stored at −70°C. RNA quality was analyzed by
agarose gel electrophoresis containing formaldehyde and
RNA concentration was measured with a Nanodrop spec-
trophotometer. Two μg of total RNA was first primed in re-
verse with oligo (dT)20 and a gene specific primer (primers
listed in Additional file 1: Table S3)using Superscript IIreverse transcriptase (Invitrogen) as recommended by sup-
plier. The first-strand cDNA was purified with the High
Pure PCR Product Purification Kit (Roche) and eluted with
100 μl of water. Real-time PCR was carried out with the
LightCyclerFastStart DNA Master SYBR Green I Kit
(Roche). The 10 μl assays contained 5 μl of cDNA template,
2.6 μl of water, 0.2 μl of each 25 μM forward and reverse
primers and 2 μl of the master mix. Pre-incubation was
performed at 95°C for 10 min, and amplification was car-
ried out as 95°C 15s; 60°C 5s; 72°C 20s for 40 cycles. Pri-
mers and amplicon sizes are described in Additional file 1:
Table S3. Beta-actin was used to normalize transcription
data. A dilution series (101-106copies) of the appropriate
cDNA subclones were included in each run and served as
an external standard to calculate the copy numbers of tran-
scripts. All assays were run in duplicate.
Electrophoretic mobility shift assay
Preparation of nuclear extracts and Electrophoretic
Mobility Shift Assays (EMSA) were performed as
described [48]. Probes were labeled radioactively with
32P-dCTP using the Klenow-fill in procedure, as
described [9]. To this end, we primed the fill-in reac-
tion on the respective “long” oligonucleotide (Add-
itional file 1: Table S4) by annealing the corresponding
“short” reverse oligonucleotide. Labeled probes and nu-
clear extracts were incubated with 10 μl of 2x binding
buffer (20 mM HEPES pH7.9, 10 mM MgCl2, 0.2 mM
EDTA pH8, 2 mM DTT, 0.1 M NaCl, 20% Glycerol,
0.4 mM PMSF) in 20 μl of volume. DNA-protein com-
plexes were separated on 4% or 6% (NF-Y or C/EBP,
respectively) non-denaturing polyacrylamide gels. Anti-
NF-YA (sc-10779x) and anti-C/EBPβ (sc-746x) anti-
bodies were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA).
Chromatin Immunoprecipitation assays
The general procedures for chromatin immunopreci-
pitation assays (ChIP) were essentially as described
[49]. Details of the experiment are shown in Add-
itional file 2: Supplementary methods.
Statistical analysis
The statistical significance of differing mean values was
assessed with Student’s t-test, as provided with the Excel
program by the Microsoft Office software.Additional files
Additional file 1: Supplementary Figures and Tables.
Additional file 2: Supplementary Material and methods. [7,47,50-
52].
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